Clinical Trial Update: A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated atomoxetine for negative symptoms in schizophrenia (and schizoaffective disorder); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: University of Pittsburgh | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED